Novavax expects COVID vaccine targeting Omicron in fourth quarter
Novavax expects COVID vaccine targeting Omicron in fourth quarter The U.S. FDA on Thursday recommended COVID-19 vaccine manufacturers change the design of their booster shots beginning this fall to include components tailored to combat the currently dominant Omicron BA.4 and BA.5 subvariants. https://ift.tt/pgTSaEk
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment